SP7 and breast carcinoma: The versatile pluripotency of the reprogrammed breast cancer cells was confirmed by other mesenchymal-related differentiation including osteogenesis and chondrogenesis with detection of osteo and chondro-specific markers such as transcription factor Sp7 (Osterix), collagen type II and sex determining region Y-box 9 (SOX9).